Cell therapy continues to attract great interest from both the research community and health care companies, not to mention biotech investors. Although the main focus is cancer, cell therapy products are showing promise in the treatment of diseases as varied as heart failure, osteoarthritis, diabetes mellitus, graft-versus-host disease and Alzheimer’s disease.
According to Informa's Pharmaprojects, more than 300 companies worldwide are developing cell therapy products, and between them they are responsible...